Evidence map›Paper›PMID 34705208›Full record

ArticleEnvironmental science and pollution research international2022

Possible enzymatic mechanism underlying chemical tolerance and characteristics of tolerant population in Scapholeberis kingi.

Makoto Ishimota, Mebuki Kodama, Naruto Tomiyama

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Makoto IshimotaLaboratory of Residue Analysis II, Chemistry Division, The Institute of Environmental Toxicology, Uchimoriya-machi, Joso-shi, 4321, Ibaraki, 303-0043, Japan. mota-4024will@hotmail.co.jp.ORCID http://orcid.org/0000-0003-4686-0244
Mebuki KodamaLaboratory of Residue Analysis II, Chemistry Division, The Institute of Environmental Toxicology, Uchimoriya-machi, Joso-shi, 4321, Ibaraki, 303-0043, Japan.
Naruto TomiyamaLaboratory of Residue Analysis II, Chemistry Division, The Institute of Environmental Toxicology, Uchimoriya-machi, Joso-shi, 4321, Ibaraki, 303-0043, Japan.
Institute of Materials and Environmental Chemistry · HUMotion Control (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To determine the potential effects of pesticides on aquatic organisms inhabiting a realistic environment, we explored the characteristics and mechanisms of chemical tolerance in Scapholeberis kingi(Cladocera). We established a chemical-tolerant population via continuous exposure to pirimicarb, an acetylcholinesterase (AChE) inhibitor, and examined the effects of pirimicarb concentration on the intrinsic growth rates (r) of tolerant cladocerans. We also explored the association between r and feeding rate and tested the involvement of antioxidant enzymes [peroxidase (PO) and superoxide dismutase] and AChE in pirimicarb sensitivity. S. kingi was continuously exposed to lethal and sublethal pirimicarb concentrations (0, 2.5, 5, and 10 µg/L) for 15 generations, and changes (half maximal effective concentration at 48 h, 48 h-EC

Indexed as

CladoceraPesticidesWater Pollutants, ChemicalAcetylcholinesteraseAnimalsCholinesterase InhibitorsAcetylcholinesteraseCholinesterase InhibitorsPesticidesWater Pollutants, ChemicalAcetylcholinesteraseCladoceraField populationInsecticideMulti-generational studyPeroxidaseSuperoxide dismutaseTolerance

Identifiers

PMID34705208
OpenAlexW3198166156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.